Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial
Makaleler > Tam Makale · 2019
Yazarlar: Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun, Kıvanç YÜKSEL
Clinical Drug Investigation, Uluslararası, Wos, 2019, cilt 39, ss 991-1001